Clinical Trial Update: CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

View source ↗

Summary

A completed clinical trial evaluating CXCR4 PET/CT as a predictor of outcomes in limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Small Cell Lung Cancer | Status: COMPLETED